The USSC actually does something decent for a change and, for the time being, has decided to allow mifepristone to be allowed to be used nationwide pending appeals.
Snip:
Earlier this month, U.S. District Judge Matthew Kacsmaryk ruled in favor of the antiabortion doctors and issued a sweeping order that would have halted sales of mifepristone nationwide.
Days later, the U.S. Fifth Circuit Court of Appeals blocked part of Kacsmaryk’s order and allowed the brand name version of the drug, Mifeprex, to remain on the market. But the appeals court judges imposed restrictions on the medication that would severely limit access.
The appeals court blocked mail delivery of the drug, imposed doctors’ visits as a condition to get the medication, and reduced the length of time when women can take the pill to the seventh week of pregnancy.
The appeals court judges also suspended the 2019 approval of the generic version of mifepristone. The company that sells the generic version, GenBioPro, told the Supreme Court that the majority of the nation’s supply of the medication would “disappear overnight” if the appeals court ruling went into effect.
_________________________________________
No comments:
Post a Comment